Bliss GVS Pharma Limited (NSE:BLISSGVS)

Bliss GVS Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 28, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	16,848	12,386	11,793	7,421	7,978	10,181
Market Cap Growth	57.01%	5.03%	58.92%	-6.98%	-21.63%	-2.08%
Enterprise Value	16,730	11,511	11,487	7,314	7,890	10,302
Last Close Price	159.60	117.40	112.00	70.16	75.51	96.09
PE Ratio	15.80	14.69	15.63	10.47	53.05	14.86
PS Ratio	2.02	1.53	1.53	0.99	1.07	1.76
PB Ratio	1.54	1.13	1.18	0.81	0.94	1.23
P/TBV Ratio	1.62	1.19	1.23	0.85	0.98	1.27
P/FCF Ratio	-	41.50	15.83	-	12.98	18.56
P/OCF Ratio	-	11.70	11.47	21.63	5.89	15.92
EV/Sales Ratio	2.01	1.42	1.49	0.97	1.06	1.79
EV/EBITDA Ratio	12.62	9.42	7.77	6.31	6.77	9.88
EV/EBIT Ratio	16.26	11.83	9.25	7.42	7.79	11.52
EV/FCF Ratio	-	38.56	15.42	-	12.83	18.78
Debt / Equity Ratio	0.08	0.08	0.10	0.11	0.13	0.15
Debt / EBITDA Ratio	0.66	0.70	0.66	0.87	0.92	1.14
Debt / FCF Ratio	-	2.95	1.34	-	1.78	2.22
Asset Turnover	-	0.65	0.65	0.66	0.68	0.55
Inventory Turnover	-	3.53	3.62	3.64	3.62	3.90
Quick Ratio	-	3.45	3.55	2.38	2.32	2.66
Current Ratio	-	4.81	5.15	3.61	3.33	3.76
Return on Equity (ROE)	-	8.62%	8.50%	8.70%	2.76%	9.37%
Return on Assets (ROA)	-	4.84%	6.56%	5.44%	5.79%	5.31%
Return on Capital (ROIC)	5.63%	5.33%	7.32%	6.24%	6.65%	6.12%
Return on Capital Employed (ROCE)	-	8.60%	11.80%	10.20%	11.60%	10.20%
Earnings Yield	6.33%	6.81%	6.40%	9.55%	1.88%	6.73%
FCF Yield	-	2.41%	6.32%	-8.02%	7.71%	5.39%
Dividend Yield	0.31%	0.43%	0.45%	0.71%	0.66%	0.52%
Payout Ratio	-	6.46%	7.15%	7.67%	35.41%	8.10%
Buyback Yield / Dilution	0.40%	0.04%	-0.56%	-0.26%	0.26%	-2.26%
Total Shareholder Return	0.71%	0.46%	-0.12%	0.45%	0.92%	-1.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.